Promising Biomarkers for Chronic Wound Healing: A Pilot Cohort Study on Wound Cytokines and a Novel Biofilm Detection Kit for Predicting 90‐Day Outcomes.

Early identification of chronic wounds is essential for clinical decision‐making in wound care. Biofilm infection is a well‐known risk factor for delayed healing, while cytokines in the wound microenvironment play critical regulatory roles throughout the healing cascade. This single‐centre prospecti...

Descripción completa

Detalles Bibliográficos
Publicado en:Wound Repair & Regeneration Vol. 33; no. 5; pp. 1 - 16
Autores principales: Wu, Yu‐Feng, Sheu, Shu‐Yun, Cheng, Nai‐Chen, Cheng, Chao‐Min
Formato: equations & formulas pictorial research tables/charts Journal Article
Publicado: Wiley-Blackwell Sep/Oct2025
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=188875057&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 188875057
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10671927
        DPV
      jtl: Wound Repair & Regeneration
      issn: 10671927
      maglogo: Y
    pubinfo:
      dt: Sep/Oct2025
      vid: 33
      iid: 5
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        188875057
        188875057
        188875057
        10.1111/wrr.70100
        188875057
      ppf: 1
      ppct: 15
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: C
          – @attributes:
              type: P
      tig:
        atl: Promising Biomarkers for Chronic Wound Healing: A Pilot Cohort Study on Wound Cytokines and a Novel Biofilm Detection Kit for Predicting 90‐Day Outcomes.
      aug:
        au:
          Wu, Yu‐Feng
          Sheu, Shu‐Yun
          Cheng, Nai‐Chen
          Cheng, Chao‐Min
        affil: Division of Plastic Surgery, Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan
      sug:
        subj:
          Wounds, Chronic Therapy
          Wound Healing
          Cytokines Analysis
          Biological Markers Analysis
          Point-of-Care Testing
          Wound Care
          Biofilms
          Prediction Models
          Wounds, Chronic Prognosis
          Treatment Outcomes
          Human
          Taiwan
          Funding Source
          Pilot Studies
          Prospective Studies
          Predictive Value of Tests
          Descriptive Statistics
          Sensitivity and Specificity
          C-Reactive Protein Blood
          Inflammation Mediators Blood
          Chemokines Blood
          ROC Curve
          Diabetes Mellitus
          Peripheral Vascular Diseases
          Biological Markers Blood
          Cytokines Blood
          Colorimetry
          Tertiary Health Care Taiwan
          Enzyme-Linked Immunosorbent Assay
          Immunoassay
          Staining and Labeling
          Wounds, Chronic Microbiology
          Unpaired T-Tests
          Pearson's Correlation Coefficient
          Chi Square Test
          Fisher's Exact Test
          Mann-Whitney U Test
          Kruskal-Wallis Test
          Post Hoc Analysis
          McNemar's Test
          Logistic Regression
          Data Analysis Software
          Adult
          Middle Age
          Aged
          Aged, 80 and Over
          Male
          Female
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Aged: 65+ years
          Aged, 80 & over
          Male
          Female
      ab: Early identification of chronic wounds is essential for clinical decision‐making in wound care. Biofilm infection is a well‐known risk factor for delayed healing, while cytokines in the wound microenvironment play critical regulatory roles throughout the healing cascade. This single‐centre prospective cohort study enrolled 66 patients with chronic wounds between 2020 and 2023 to evaluate cytokine biomarkers and biofilm detection tools for predicting wound outcomes. Clinical signs of biofilm (CSB) alone demonstrated limited predictive value, with accuracies of 66.7% for 30‐day and 45.5% for 90‐day healing. In contrast, the Wound Biofilm Detection Kit (WBDK) showed superior performance, achieving predictive accuracies of 92.4% and 60.6% for 30‐ and 90‐day outcomes, respectively, outperforming both CSB and MolecuLight i:X. Cytokine analysis identified serum CRP, wound CRP and wound MCP‐1 as significant predictors, with ROC analysis demonstrating good discriminative ability for wound CRP (AUC = 0.863) and wound MCP‐1 (AUC = 0.830). A simplified Lasso regression model incorporating diabetes mellitus, peripheral arterial disease, wound location and WBDK grade achieved an AUC of 0.77 and an accuracy of 76% for 90‐day outcomes. External validation was performed in 17 additional patients yielding a predictive accuracy of 76.5%, supporting the robustness of the model. These findings highlight the limited reliability of clinical signs alone and emphasise the value of objective biofilm detection and cytokine profiling in wound prognosis. Our high‐accuracy prediction model, based on readily accessible clinical variables and WBDK results, may facilitate precision wound care and improve real‐time management.
      pubtype: Academic Journal
      doctype:
        equations & formulas
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N